Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126160781 | 12616078 | 1 | I | 20160722 | 20160802 | 20160802 | EXP | FR-SA-2016SA135161 | AVENTIS | 50.00 | YR | A | F | Y | 0.00000 | 20160802 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126160781 | 12616078 | 1 | PS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Subcutaneous | U | UNK | 21081 | 26 | IU | |||||||
| 126160781 | 12616078 | 2 | C | SOLOSTAR | DEVICE | 1 | 0 | ||||||||||||
| 126160781 | 12616078 | 3 | C | HUMALOG | INSULIN LISPRO | 1 | MORNING, MIDDAY AND EVENING | 0 | TID | ||||||||||
| 126160781 | 12616078 | 4 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | STRENGTH: 20 MG | 0 | 1 | DF | QD | ||||||||
| 126160781 | 12616078 | 5 | C | INEXIUM | ESOMEPRAZOLE | 1 | STRENGTH: 40 MG | 0 | 1 | DF | QD | ||||||||
| 126160781 | 12616078 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | STRENGTH: 160 MG | 0 | 1 | DF | QD | ||||||||
| 126160781 | 12616078 | 7 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 0 | 1 | DF | QD | |||||||||
| 126160781 | 12616078 | 8 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 0 | 4 | DF | QD | |||||||||
| 126160781 | 12616078 | 9 | C | VITAMINS NOS | VITAMINS | 1 | 0 | 1 | DF | QD | |||||||||
| 126160781 | 12616078 | 10 | C | CALCIPRAT | 2 | 0 | 2 | DF | QD | ||||||||||
| 126160781 | 12616078 | 11 | C | UVEDOSE | CHOLECALCIFEROL | 1 | DOSE: 1 VIAL/3MONTHS | 0 | |||||||||||
| 126160781 | 12616078 | 12 | C | APIDRA | INSULIN GLULISINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126160781 | 12616078 | 1 | Type 1 diabetes mellitus |
| 126160781 | 12616078 | 2 | Type 1 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126160781 | 12616078 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126160781 | 12616078 | Condition aggravated | |
| 126160781 | 12616078 | Diabetic ketoacidosis | |
| 126160781 | 12616078 | Pain in extremity | |
| 126160781 | 12616078 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126160781 | 12616078 | 1 | 2013 | 0 | ||
| 126160781 | 12616078 | 2 | 2013 | 0 |